Shuttle Pharmaceuticals Holdings IncSHPH
Price$3.95

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 31 Dec 2025
Net Income -$11.7MTTM through 31 Dec 2025
Free Cash Flow -$9.5MTTM through 31 Dec 2025

Margins

Current

Returns

-114.7%ROA

Balance Sheet Health

Debt / Equity0.10x
Current Ratio0.06x
Net Debt-$101.9Knet cash position
Cash & Equivalents$334K

Dividend

No dividend

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.